Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction

Abstract Aims An increasing proportion of patients with heart failure with reduced ejection fraction (HFrEF) have co‐morbidities. The effect of these co‐morbidities on modes of death and the effect of disease‐modifying agents in multi‐morbid patients is unknown. Methods and results We performed a pr...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Sam Straw, Melanie McGinlay, Samuel D. Relton, Aaron O. Koshy, John Gierula, Maria F. Paton, Michael Drozd, Judith E Lowry, Charlotte Cole, Richard M Cubbon, Klaus K. Witte, Mark T. Kearney
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Oxford University Press 2020-12-01
Rangatū:	ESC Heart Failure
Ngā marau:	Heart failure Sudden cardiac death Co‐morbidities
Urunga tuihono:	https://doi.org/10.1002/ehf2.12978
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!